1. Home
  2. NNNN vs ICFI Comparison

NNNN vs ICFI Comparison

Compare NNNN & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • ICFI
  • Stock Information
  • Founded
  • NNNN 2021
  • ICFI 1969
  • Country
  • NNNN Germany
  • ICFI United States
  • Employees
  • NNNN N/A
  • ICFI N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ICFI Professional Services
  • Sector
  • NNNN Health Care
  • ICFI Consumer Discretionary
  • Exchange
  • NNNN Nasdaq
  • ICFI Nasdaq
  • Market Cap
  • NNNN 2.2B
  • ICFI 1.8B
  • IPO Year
  • NNNN 2025
  • ICFI 2006
  • Fundamental
  • Price
  • NNNN $45.65
  • ICFI $99.80
  • Analyst Decision
  • NNNN
  • ICFI Buy
  • Analyst Count
  • NNNN 0
  • ICFI 4
  • Target Price
  • NNNN N/A
  • ICFI $116.75
  • AVG Volume (30 Days)
  • NNNN 88.1K
  • ICFI 185.0K
  • Earning Date
  • NNNN 01-01-0001
  • ICFI 10-30-2025
  • Dividend Yield
  • NNNN N/A
  • ICFI 0.56%
  • EPS Growth
  • NNNN N/A
  • ICFI 10.29
  • EPS
  • NNNN 0.06
  • ICFI 5.74
  • Revenue
  • NNNN $8,185,146.00
  • ICFI $1,977,095,000.00
  • Revenue This Year
  • NNNN N/A
  • ICFI N/A
  • Revenue Next Year
  • NNNN N/A
  • ICFI $3.41
  • P/E Ratio
  • NNNN $839.78
  • ICFI $17.36
  • Revenue Growth
  • NNNN 21.95
  • ICFI N/A
  • 52 Week Low
  • NNNN $5.18
  • ICFI $75.91
  • 52 Week High
  • NNNN $55.65
  • ICFI $179.67
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • ICFI 65.85
  • Support Level
  • NNNN N/A
  • ICFI $96.43
  • Resistance Level
  • NNNN N/A
  • ICFI $100.08
  • Average True Range (ATR)
  • NNNN 0.00
  • ICFI 2.55
  • MACD
  • NNNN 0.00
  • ICFI -0.20
  • Stochastic Oscillator
  • NNNN 0.00
  • ICFI 71.58

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

Share on Social Networks: